醫療新知兒童尿路感染:不需昂貴檢查,簡單血液測試可判斷嚴重程度 Posted on 2024-01-082024-02-21 by Wine-Font 08 1 月 Continue reading →
醫療新知C-反應蛋白水平可預測社區獲得性肺炎的嚴重程度及併發症 Posted on 2024-01-052024-02-21 by Wine-Font 05 1 月 Continue reading →
醫療新知突破性研究:Dapagliflozin對風濕性心臟病二尖瓣狹窄患者的新希望 Posted on 2024-01-042024-01-26 by Wine-Font 04 1 月 達格列净對風濕性心臟病二尖瓣狹窄患者有積極影響:降低NT-pro BNP水平,增強左心房功能,減少二尖瓣平均壓力梯度。 Continue reading →
醫療新知DAPA-HF試驗揭示:Dapagliflozin顯著改善心力衰竭患者的生存質量 Posted on 2024-01-032024-01-26 by Wine-Font 03 1 月 Continue reading →
醫療新知心衰患者新希望:Dapagliflozin對不同NT-proBNP水平患者的顯著治療效果 Posted on 2024-01-032024-01-26 by Wine-Font 03 1 月 Continue reading →
醫療新知突破性心衰治療:Dapagliflozin對不同射血分數患者的全面效益 Posted on 2024-01-022024-01-26 by Wine-Font 02 1 月 Continue reading →
醫療新知突破性研究:達格列净有效改善輕度降低或保持正常的心臟射血分數患者心臟衰竭情況 Posted on 2024-01-022024-01-26 by Wine-Font 02 1 月 Continue reading →
醫療新知睡眠時間減少與睡眠質量下降 或增加非酒精性脂肪肝風險 Posted on 2023-12-292024-01-26 by Wine-Font 29 12 月 Continue reading →
醫療新知中老年人的睡眠行為與代謝功能障礙相關脂肪肝疾病風險研究 Posted on 2023-12-292024-01-26 by Wine-Font 29 12 月 Continue reading →
醫療新知ADVANCE試驗揭示:關鍵生物標誌物預測2型糖尿病患者心臟衰竭風險 Posted on 2023-12-292024-01-26 by Wine-Font 29 12 月 Continue reading →
醫療新知糖尿病患者心衰風險評估新突破:TnT和NT-proBNP的聯合預測價值 Posted on 2023-12-292024-01-26 by Wine-Font 29 12 月 Continue reading →